ConcertAI, a Startup Focused on Cancer Research, Raises $150 Million

29-Mar-2022 by Brian Gormley
(May Require Subscription)

The firm uses AI to match patients to specific clinical trials, and to make jumbled medical data AI-ready to sift for more insights. Sixth Street provided funding that values the firm at $1.9 billion.

ConcertAI LLC has raised $150 million to expand a business that uses software and data to help speed clinical research into different types of cancer and to match patients with clinical trials and medications.

Read More